RN7SL19P

Across TCGA pan-cancer cohorts, RN7SL19P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RN7SL19P data layer.

The strongest signal is observed in brain lower grade glioma (LGG), where higher RN7SL19P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL19P expression acts as an unfavorable survival marker, although some lineages such as BLCA and LUAD show a favorable association.

LGG, BLCA, and COAD are the cancer types where RN7SL19P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	OS	Median	All	0.713	0.883	<.001	54	view →
BLCA	OS	Tertile	III,IV	0.749	0.614	.004	43	view →
COAD	OS	Tertile	IV	0.225	0.621	.015	24	view →
LUAD	DFS	Median	II,III,IV	0.807	0.623	.002	23	view →
PCPG	DFS	Tertile	All	0.417	0.791	.002	18	view →
CESC	DFS	Tertile	All	0.906	0.799	.032	12	view →
CHOL	OS	Median	III,IV	0.286	1.000	.008	12	view →
ESCA	OS	Quartile	All	0.571	0.317	.012	10	view →
KIRC	DFS	Quartile	IV	0.536	0.284	.010	8	view →
UCS	DFS	Median	IV	0.886	0.443	.031	6	view →
STAD	DFS	Tertile	IV	0.243	0.805	.049	6	view →
BRCA	DFS	Quartile	All	0.935	0.892	.021	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RN7SL19P–LGG (OS)

Open the LGG breakdown →